Lantan Viatris 500 mg tablete za žvakanje
Name | Lantan Viatris 500 mg tablete za žvakanje |
---|---|
Marketing Authorisation Number | HR-H-708522317 |
Active Substance | lantan karbonat |
Composition | jedna tableta za žvakanje od 500 mg sadrži količinu lantan karbonat oktahidrata ekvivalentnu 500 mg lantana |
Pharmaceutical Form | tableta za žvakanje |
Manufacturer | McDermott Laboratories Limited, t/a Gerard Laboratories, Dublin 13, Irska Mylan Hungary Kft, Komárom, Mađarska Mylan Germany GmbH , Bad Homburg, Hesse, Njemačka |
Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
Marketing Authorisation Date | 20.02.2024 |
MA Period of Validity | 18.01.2026 |
Classification Number | UP/I-530-09/18-01/218 |
Registration Number | 381-12-01/171-24-20 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | V03AE03 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |